Výsledky vyhledávání - "Svetlana Achsanov"

Comparison between Roche and Xpert in HIV-1 RNA quantitation: A high concordance between the two techniques except for a CRF02_AG subtype variant with high viral load titters detected by Roche but undetected by Xpert

Autor: Simona Gielman, Boaz Avidor, Dan Turner, Svetlana Achsanov, Amos Adler, Inbal Schweitzer, Natalia Matus, Shirley Girshengorn, Irene Zeldis

Publikováno v: Journal of Clinical Virology. 93:15-19

Background HIV-1 viral load (VL) testing is important to predict viral progression and to monitor the response to antiretroviral therapy. New HIV-1 VL tests are continuously introduced to the market. Their performance is usually compared to Abbott an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2760c12a75af6976f46873022e804dac
https://doi.org/10.1016/j.jcv.2017.05.014

Zobrazit plný text záznamu

Evaluation of the virtues and pitfalls in an HIV screening algorithm based on two fourth generation assays - A step towards an improved national algorithm

Autor: Svetlana Achsanov, Boaz Avidor, Shirley Girshengorn, Licita Schreiber, Inbal Schweizer, Natalia Matus, Zipi Kra-Oz, Dan Turner, Irene Zeldis, Simona Gielman, Daniel Chemtob, Lilya Baskin

Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 106

Background Fourth-generation immunoassays used for HIV screening, simultaneously detect anti-HIV antibodies and HIV-1 P24 antigen, but are prone to false-positive results. Usually, they are followed by highly specific third-generation assay, able to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3c5db809c836c709a46d16971d28b1
https://pubmed.ncbi.nlm.nih.gov/30007138

Zobrazit plný text záznamu

Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory

Autor: Danny Alon, Israel Yust, Boaz Avidor, Shirley Girshengorn, Svetlana Achsanov, Ilana S. Fratty, Zvi Bentwich, David Hassin, Tal Brosh-Nissimov, Irene Zeldis, Hadass Talio, Natalia Matus, Ina Vulih Shultsman, Sharon Amit, Eugene Katchman, Relly Forer, Dan Turner

Publikováno v: Journal of clinical microbiology. 51(3)

Detection of low-abundance drug resistance mutations (DRMs) of HIV-1 is an evolving approach in clinical practice. Ultradeep pyrosequencing has shown to be effective in detecting such mutations. The lack of a standardized commercially based assay lim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08d4a948da927963880cd52bd6b1dd3
https://pubmed.ncbi.nlm.nih.gov/23284027

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání